Implications for Practice Due to the established connection between GLP-1 agonists and DR, optometrists should err on the side of caution and be in contact with primary care physicians on whether GLP-1/gastric inhibitory polypeptide (GIP) agonists should be prescribed in patients who have existing DR
Reliable sources of information include reputable medical websites, diabetes organizations, and peer-reviewed journals
According to the World Health Organization (WHO), more than 1 billion individuals are suffering from obesity, worldwide
However, in the various populations with steroid-induced dysglycemia, GLP-1 RAs have demonstrated efficacy in improving glycemic control and supporting weight reduction, with additional reported renal and cardiovascular benefits
Designed to support cellular health, immune strength, and liver function, this powerful formula helps you feel and look your best every day